293 related articles for article (PubMed ID: 19236470)
1. Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis.
Kuhle J; Lindberg RL; Regeniter A; Mehling M; Steck AJ; Kappos L; Czaplinski A
Eur J Neurol; 2009 Jun; 16(6):771-4. PubMed ID: 19236470
[TBL] [Abstract][Full Text] [Related]
2. CSF chemokine alterations related to the clinical course of amyotrophic lateral sclerosis.
Tateishi T; Yamasaki R; Tanaka M; Matsushita T; Kikuchi H; Isobe N; Ohyagi Y; Kira J
J Neuroimmunol; 2010 May; 222(1-2):76-81. PubMed ID: 20381883
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis.
Tanaka M; Kikuchi H; Ishizu T; Minohara M; Osoegawa M; Motomura K; Tateishi T; Ohyagi Y; Kira J
J Neuropathol Exp Neurol; 2006 Aug; 65(8):816-25. PubMed ID: 16896315
[TBL] [Abstract][Full Text] [Related]
4. Increased cerebrospinal fluid levels of cytokines monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1β (MIP-1β) in patients with amyotrophic lateral sclerosis.
Martínez HR; Escamilla-Ocañas CE; Camara-Lemarroy CR; González-Garza MT; Moreno-Cuevas J; García Sarreón MA
Neurologia (Engl Ed); 2020 Apr; 35(3):165-169. PubMed ID: 29029824
[TBL] [Abstract][Full Text] [Related]
5. IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus.
Yoshio T; Okamoto H; Kurasawa K; Dei Y; Hirohata S; Minota S
Lupus; 2016 Aug; 25(9):997-1003. PubMed ID: 26846690
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers.
Rothenbacher D; Müller-Scholze S; Herder C; Koenig W; Kolb H
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):194-9. PubMed ID: 16239601
[TBL] [Abstract][Full Text] [Related]
7. RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
Rentzos M; Nikolaou C; Rombos A; Boufidou F; Zoga M; Dimitrakopoulos A; Tsoutsou A; Vassilopoulos D
Amyotroph Lateral Scler; 2007 Oct; 8(5):283-7. PubMed ID: 17852013
[TBL] [Abstract][Full Text] [Related]
8. Elevation of MCP-1 and MCP-1/VEGF ratio in cerebrospinal fluid of amyotrophic lateral sclerosis patients.
Nagata T; Nagano I; Shiote M; Narai H; Murakami T; Hayashi T; Shoji M; Abe K
Neurol Res; 2007 Dec; 29(8):772-6. PubMed ID: 17672928
[TBL] [Abstract][Full Text] [Related]
9. Production of monocyte chemoattractant protein-1 in amyotrophic lateral sclerosis.
Baron P; Bussini S; Cardin V; Corbo M; Conti G; Galimberti D; Scarpini E; Bresolin N; Wharton SB; Shaw PJ; Silani V
Muscle Nerve; 2005 Oct; 32(4):541-4. PubMed ID: 15962273
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal synthesis of monocyte chemoattractant protein-1 (MCP-1) in amyotrophic lateral sclerosis: further evidence for microglial activation in neurodegeneration.
Wilms H; Sievers J; Dengler R; Bufler J; Deuschl G; Lucius R
J Neuroimmunol; 2003 Nov; 144(1-2):139-42. PubMed ID: 14597108
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory markers in cerebrospinal fluid: independent prognostic biomarkers in amyotrophic lateral sclerosis?
Gille B; De Schaepdryver M; Dedeene L; Goossens J; Claeys KG; Van Den Bosch L; Tournoy J; Van Damme P; Poesen K
J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1338-1346. PubMed ID: 31175169
[TBL] [Abstract][Full Text] [Related]
12. Serum chemokine levels in major depressive disorder.
Lehto SM; Niskanen L; Herzig KH; Tolmunen T; Huotari A; Viinamäki H; Koivumaa-Honkanen H; Honkalampi K; Ruotsalainen H; Hintikka J
Psychoneuroendocrinology; 2010 Feb; 35(2):226-32. PubMed ID: 19592174
[TBL] [Abstract][Full Text] [Related]
13. Multiplex determination of murine seminal fluid cytokine profiles.
Gopichandran N; Ekbote UV; Walker JJ; Brooke D; Orsi NM
Reproduction; 2006 Mar; 131(3):613-21. PubMed ID: 16514204
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease.
Galimberti D; Schoonenboom N; Scheltens P; Fenoglio C; Bouwman F; Venturelli E; Guidi I; Blankenstein MA; Bresolin N; Scarpini E
Arch Neurol; 2006 Apr; 63(4):538-43. PubMed ID: 16606766
[TBL] [Abstract][Full Text] [Related]
15. Altered chemokine levels in the cerebrospinal fluid and plasma of suicide attempters.
Janelidze S; Ventorp F; Erhardt S; Hansson O; Minthon L; Flax J; Samuelsson M; Traskman-Bendz L; Brundin L
Psychoneuroendocrinology; 2013 Jun; 38(6):853-62. PubMed ID: 23062672
[TBL] [Abstract][Full Text] [Related]
16. Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: specificity, sensitivity, and a possible prognostic value.
Noto Y; Shibuya K; Sato Y; Kanai K; Misawa S; Sawai S; Mori M; Uchiyama T; Isose S; Nasu S; Sekiguchi Y; Fujimaki Y; Kasai T; Tokuda T; Nakagawa M; Kuwabara S
Amyotroph Lateral Scler; 2011 Mar; 12(2):140-3. PubMed ID: 21126161
[TBL] [Abstract][Full Text] [Related]
17. Time course of chemokines in the cerebrospinal fluid and serum during herpes simplex type 1 encephalitis.
Rösler A; Pohl M; Braune HJ; Oertel WH; Gemsa D; Sprenger H
J Neurol Sci; 1998 Apr; 157(1):82-9. PubMed ID: 9600681
[TBL] [Abstract][Full Text] [Related]
18. Concentrations of macrophage inflammatory proteins MIP-1alpha and MIP-1beta and interleukin 8 (il-8) in lyme borreliosis.
Grygorczuk S; Pancewicz S; Zajkowska J; Kondrusik M; Rwierzbińska R; Hermanowska-Szpakowicz T
Infection; 2004 Dec; 32(6):350-5. PubMed ID: 15597225
[TBL] [Abstract][Full Text] [Related]
19. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue.
Henkel JS; Engelhardt JI; Siklós L; Simpson EP; Kim SH; Pan T; Goodman JC; Siddique T; Beers DR; Appel SH
Ann Neurol; 2004 Feb; 55(2):221-35. PubMed ID: 14755726
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Chitotriosidase and CC-Chemokine Ligand 18 as Biomarkers of Microglia Activation in Amyotrophic Lateral Sclerosis.
Martinez-Merino L; Iridoy M; Galbete A; Roldán M; Rivero A; Acha B; Irún P; Canosa C; Pocoví M; Mendioroz M; Jericó I
Neurodegener Dis; 2018; 18(4):208-215. PubMed ID: 30134252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]